News

MM-121 is a fully human monoclonal antibody that targets ErbB3. The Phase 2 study will assess efficacy of MM-121 in combination with paclitaxel as compared to treatment with

The study MODERN [Maraviroc Once daily with Darunavir Enhanced by Ritonavir in a Novel regimen] or A4001095 will test the efficacy of Celsentri/Selzentry (maraviroc) versus emtricitabine/tenofovir (Truvada), both

The move in this direction has been made on the back of growing potential in the Brazilian pharma market. Celesio CEO Markus Pinger said Brazil’s healthcare market grows

Other Azelon investors are Lighthouse Capital Partners and Covington Venture Fund. ZT-034, which comprises teriparatide (PTH1-34) is said to provide an alternative for patients at high risk of

The new plant will manufacture both intravenous and oral solid medicines. According to the company, the new plant will help meet the rising demand for its products in

Anacor has entered into partnership and works with UCSF to discover new antimalarial agents. Anacor discovers, develops small-molecule therapeutics derived from its boron chemistry platform. In addition Anacor

Edgemont’s Fluoxetine 60 mg tablet is a single pill which is used to treat major depressive disorder, obsessive compulsive disorder in adults and pediatrics, and bulimia nervosa and

DMC has recommended that the LibiGel safety study should continue as per the FDA-agreed protocol. LibiGel is a testosterone gel used to treat female sexual dysfunction (FSD), specifically

Brana Vita is rich in arabinoxylan oligosaccharides (AXOS), soluble fibers derived from the cell walls of wheat bran. The AXOS are potent prebiotics which stimulates the growth of